ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $568,681 | -69.4% | 27,288 | -64.9% | 0.02% | -68.6% |
| Q2 2023 | $1,860,652 | -49.8% | 77,689 | -60.5% | 0.07% | -54.5% |
| Q1 2023 | $3,705,846 | +1631.7% | 196,910 | +1403.1% | 0.15% | +1825.0% |
| Q3 2022 | $214,000 | -89.2% | 13,100 | -90.7% | 0.01% | -90.7% |
| Q2 2022 | $1,984,000 | +23.7% | 140,769 | +112.5% | 0.09% | +24.6% |
| Q1 2022 | $1,604,000 | -16.8% | 66,244 | -16.2% | 0.07% | -62.9% |
| Q2 2021 | $1,928,000 | – | 79,060 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |